Filing Flows › Nexgel (NXGL) › Q1 2026 › vs Q4 2025
Nexgel (NXGL) Q1 2026 vs Q4 2025 (quarter over quarter)
Nexgel's revenue fell $146K (-5%) from $2.8M in Q4 2025 to $2.6M in Q1 2026.
Nexgel, Q1 2026: revenue $2.6M (-6% year over year), operating margin -36.2%, net loss $871K, operating cash flow −$504K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.6M | $2.8M | −$146K | -5% |
| Other income, net | $87K | $286K | −$199K | -70% |
| Net loss | $871K | $928K | −$57K | -6% |
| Costs & expenses | $3.6M | $4.0M | −$402K | -10% |
| Operating costs | $3.6M | $4.0M | −$402K | -10% |
| Cost of revenue | $1.6M | $2.0M | −$388K | -20% |
| Operating expenses | $2.0M | $2.0M | −$14K | -0.7% |
| Operating cash sources | $871K | $928K | −$57K | -6% |
| Depreciation & amortization | $99K | $112K | −$13K | -12% |
| Share-based compensation | $143K | $156K | −$13K | -8% |
| Working capital & other | $125K | $941K | −$816K | -87% |
| Cash used in operations | $504K | −$281K | $785K | — |
| Net loss absorbed | $871K | $928K | −$57K | -6% |
Questions
How much did Nexgel's revenue grow quarter over quarter in Q1 2026?
Nexgel's revenue fell $146K (-5%) from $2.8M in Q4 2025 to $2.6M in Q1 2026.